Table 2. Maximum plasma concentration of components derived from goshajinkigan (GJG) after oral administration of GJG in rats.
| Crude drugs | Compound | Cmax (ng/mL) | Tmax (h) |
|---|---|---|---|
| processed Aconiti tuber | Benzoylaconinea | 0.012 ± 0.002 | 0.50 ± 0.00 |
| Benzoylmesaconinea | 0.041 ± 0.006 | 0.44 ± 0.13 | |
| Benzoylhypaconinea | 0.013 ± 0.001 | 0.50 ± 0.00 | |
| 14-Anisoylaconinea | 0.009 ± 0.000 | 0.31 ± 0.13 | |
| Corni fructus | Loganinb | 43.7 ± 25.7 | 0.58 ± 0.20 |
| Morronisideb | 53.7 ± 26.9 | 0.67 ± 0.26 | |
| Rehmanniae radix | Catalpolb | 282.3 ± 118.7 | 1.00 ± 0.55 |
| Moutan coutex | Paeoniflorinb | 9.1 ± 1.2 | 0.58 ± 0.20 |
Mean ± S.D.; aN = 4, bN = 6. Cmax: maximum plasma concentration. Tmax: time to reach maximum plasma concentration.